Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
1. 系统已在2025-04-28 15:04:10对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1038/s41591-025-03638-2
文献链接: https://www.nature.com/articles/s41591-025-03638-2
其他信息:
出版社: Springer Science and Business Media LLC
作者: Shen Zhao; Ying Cheng; Qiming Wang; Xingya Li; Jun Liao; Jordi Rodon; Xiangjiao Meng; Yongzhong Luo; Zhendong Chen; Wei Wang; Tienan Yi; Yongsheng Li; Yongmei Yin; Huiting Xu; Guohua Yu; Yanjun Mi; Yun Fan; Zev A. Wainberg; Xiang Wang; Cuiyun Su; Qitao Yu; Shuzhen Lai; Longhua Sun; Wu Zhuang; Xian Wang; Jiacheng Yang; Yaling Li; Junyou Ge; Jin Li; Li Zhang; Wenfeng Fang
全文下载地址: https://www.nature.com/articles/s41591-025-03638-2.pdf
